Randomized clinical trials of pregabalin for neuropathic pain: Methods, results, and implications

Progress in Neurotherapeutics and Neuropsychopharmacology

Volumn 3, Issue 1, 2008, Pages 167-187

  Dworkin, Robert H ^a   Thakur, Rajbala ^a   Griesing, Teresa ^b   Sharma, Uma ^b   Young, James P ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b PFIZER INC   (United States)

Author keywords

Diabetic peripheral neuropathy; Neuropathic pain; Postherpetic neuralgia; Pregabalin; Randomized clinical trials; Spinal cord injury

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; NARCOTIC ANALGESIC AGENT; OPIATE; PLACEBO; PREGABALIN;

AMBLYOPIA; ARTICLE; ASTHENIA; BLOOD PRESSURE; BLURRED VISION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; COORDINATION DISORDER; DIABETIC NEUROPATHY; DIZZINESS; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECG ABNORMALITY; EUPHORIA; GAIT DISORDER; HEART RATE; HUMAN; INFECTION; MEMORY DISORDER; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SOMNOLENCE; SPINAL CORD INJURY; STUPOR; THINKING IMPAIRMENT; WEIGHT GAIN; XEROSTOMIA;

EID: 39449120699     PISSN: 17482321     EISSN: 1748233X     Source Type: Journal    
DOI: 10.1017/S1748232107000080     Document Type: Article

References (47)

1. Argoff, C.E., Backonja, M.-M., Belgrade, M.J., Bennett, G.J., Clark, M.R., Cole, B.E., et al. (2006). Consensus guidelines: treatment planning and options. Mayo Clinic Proceedings, 81(Suppl.), S12-S25.
2. 2-δ protein. Journal of Medicinal Chemistry, 48, 2294-2307.
3. Bowsher, D. (1999). The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: A retrospective survjey in an elderly population. European Journal of Pain, 3, 335-342.
4. Crofford, L.J., Rowbotham, M.C., Mease, P.J., Russell, I.J., Dworkin, R.H., Corbin, A.E., et al. (2005). Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism, 52, 1264-1273.
5. 2δ ligands: Novel modulators of neurotransmission. Trends in Pharmacological Sciences, 28, 75-82.
6. Dubinsky, R.M., Kabbani, H., El-Chami, Z., Boutwell, C., & Ali, H. (2004). Practice parameter: TreAtment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 63, 959-965.
7. Dworkin, R.H., Backonja, M., Rowbotham, M.C., Allen, R.R., Argoff, C.R., Bennett, G.J., et al. (2003a). Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Archives of Neurology, 60, 1524-1534.
8. Dworkin, R.H., Corbin, A.E., Young, Jr., J.P., Sharma, U., LaMoreaux, L., Bockbrader, H., et al. (2003b). Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology, 60, 1274-1283.
9. Dworkin, R.H., Fields, H.L., & Levine, J.D. (eds.) (2005a). Is fibromyalgia a neuropathic pain syndrome? Journal of Rheumatology, 32(Suppl. 75), 1-45.
10. Dworkin, R.H., Katz, J., & Gitlin, M.J. (2005b). Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain. Neurology, 65 (Suppl. 4), S7-S19.
11. Dworkin, R.H., Sharma, U., Young, J., & LaMoreaux, L. (2005c). Pain relief with pregabalin in postherpetic neuralgia (PHN) is not influenced by concomitant medications. Journal of Pain, 6(Suppl. 1), S32.
12. Dworkin, R.H., Turk, D.C., Farrar, J.T., Haythornthwaite, J.A., Jensen, M.P., Katz, N.P., et al. (2005d). Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain, 113, 9-19.
13. Dworkin, R.H., O'Connor, A.B., Backonja, M., Farrar, J.T., Jensen, T.S., Kalso, E.A., et al. (in press). Pharmacologic management of neuropathic pain: Evidence-based clinical recommendations. Pain.
14. Farrar, J.T., Young, J.P., LaMoreaux, L., Werth, J.L., & Poole, M. (2001). Clinical importance of changes in chronic pain intensity on an 11-point numerical pain rating scale. Pain, 94, 149-158.
15. Farrar, J.T., Dworkin, R.H., & Max, M.B. (2006). Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: Making clinical trial data more understandable. Journal of Pain and Symptom Management, 31, 369-377.
16. 2-δ-1 subunit of voltage dependent calcium channels as a novel molecular target for pain mediating the analgesic actions of pregabalin. Proceedings of the National Academy of Sciences USA, 103, 17537-17542.
17. Finnerup, N.B., Otto, M., Jensen, T.S., & Sindrup, S.H. (2005). Algorithm for neuropathic pain treatment: An evidence based proposal. Pain, 118, 289-305.
18. Freynhagen, R., Strojek, K., Griesing, T., Whalen, E., & Balkenohl, M. (2005). Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain, 115, 254-263.
19. Goldstein, D.J., Lu, Y., Detke, M.J., Lee, T.C., & Iyengar, S. (2005). Duloxetine vs. placebo in patients with painfull diabetic neuropathy. Pain, 116, 109-118.
20. Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology (DHEW Publication No. ADM 76-338). Washington, DC: U.S. Government Printing Office.
21. Hempenstall, K., Nurmikko, T.J., Johnson, R.W., A'Hern, R.P., & Rice, A.S.C. (2005). Analgesic therapy in postherpetic neuralgia: A quantitative systematic review. PLOS Medicine, 2, 628-644.
22. IASP Special Interest Group on Neuropathic Pain (2006). Classification and taxonomy. Neuropathic Pain: Newsletter of the IASP Special Interest Group on Neuropathic Pain, Issue 7.
23. Jensen, M.P., Chodroff, M.J., & Dworkin, R.H. (2007). The impact of neuropathic pain on health-related quality of life: Review and implications. Neurology, 68, 1178-1182.
24. Kieburtz, K., Simpson, D., Yiannoutsos, C., Max, M.B., Hall, C.D., Ellis, R.J., et al. (1998). A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology, 51, 1682-1688.
25. Lesser, H., Sharma, U., LaMoreaux, L., & Poole, R.M. (2004). Pregabalin relieves symptoms of painful diabetic neuropathy. Neurology, 63, 2104-2110.
26. Melzack, R. (1987). The short-form McGill Pain Questionnaire. Pain, 30, 191-197.
27. Merskey, H., & Bogduk, N. (eds.) (1994). Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms (2nd ed.). Seattle, WA: IASP Press, p. 212.
28. Moscucci, M., Byrne, L., Weintraub, M., & Cox, C. (1987). Blinding, unblinding, and the placebo effect: An analysis of patients' guesses of treatment assignment in a double-blind clinical trial. Clinical Pharmacology and Therapeutics, 41, 259-265.
29. Oster, G., Harding, G., Dukes, E., Edelsberg, J., & Cleary, P.D. (2005). Pain, medication use and health-related quality of life in older persons with post-herpetic neuralgia: Results from a population-based survey. Journal of Pain, 6, 356-363.
30. Raskin, J., Pritchett, Y.L., Wang, F., D'Souza, D.N., Waninger, A.L., Iyengar, S., et al. (2005). A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Medicine, 6, 346-356.
31. Rice, A.S.C., & Maton, S. (2001). Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 94, 215-224.
32. Richter, R.W., Portenoy, R., Sharma, U., Lamoreaux, L., Bockbrader, H., & Knapp, L.E. (2005). Relief of painfill diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. Journal of Pain, 6, 253-260.
33. Rosenstock, J., Tuchmson, M., LaMoreaux, L., & Sharma, U. (2004). Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain, 110, 628-638.
34. Rowbotham, M., Young, J.R., Sharma, U., & Knapp, L.K. (2003). Pregabalin shows reduction in pain by day 3 of treatment. European Journal of Neurology, 10(Suppl. 1), 73.
35. Rowbotham, M.C., Harden, N., Stacey, W., Bernstein, P., & Magnus-Miller, L. (1998). Gabapentin for the treatment postherpetic neuralgia: A randomized controlled trial. JAMA, 280, 1837-1842.
36. Sabatowski, R., Galvez, R., Cherry, D.A., Jacquot, F., Vincent, E., Maisonobe, M., et al. (2004). Pregabalin reduces pain and improved sleep and mood disturbances in patients with postherpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain, 109, 26-35.
37. Schmader, K.E. (2002). The epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clinical Journal of Pain, 18, 350-354.
38. Sharma, U., Young, J., LaMoreaux, L., Emir, B., Fukui, A., Murphy, T.K., & Siffert, J. (2005). Efficacy, safety, and tolerability of pregabalin treatment for neuropathic pain: Findings from the analysis of 10 randomized clinical trials. Presented at the meeting of the American Academy of Physical Medicine and Rehabilitation, 27-30 October 2005, Philadelphia, Pennsylvania.
39. Shlay, J.C., Chaloner, K., Max, M.B., Flaws, B., Reichelderfer, P., Wentworth, D., et al. (1998). Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: A randomized controlled trial. JAMA, 280, 1590-1595.
40. Siddall, P.J., Cousins, M.J., Otte, A., Griesing, T., Chambers, R., & Murphy, T.K. (2006). Pregabalin in central neuropathic pain associated with spinal cord injury: A placebo-controlled trial. Neurology, 67, 1702-1800.
41. 2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Research, 73, 137-150.
42. Turk, D.C., Dworkin, R.H., Allen, R.R., Bellamy, N., Brandenburg, N., Carr, D.B., et al. (2003). Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain, 106, 337-345.
43. Turk, D.C., Dworkin, R.H., Burke, L.B., Gershon, R., Rothman, M., Scott, J., et al. (2006). Developing outcome measures for pain clinical trials: IMMPACT recommendations. Pain, 125, 208-215.
44. Van Seventer, R., Feister, H.A., Young, Jr., J.P., Stoker, M., Versavel, M., & Rigaudy, L. (2006). Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial. Current Medical Research and Opinion, 22, 375-384.
45. Ware, Jr., J.E., Snow, K.K., Kosinski, M., & Gandek, B. (1992). SF-36-item Short Form Health Survey (SF-36):I. conceptual framework and item selection. Medical Care, 30, 473-483.
46. Wernicke, J.F. Pritchett, Y.L., D'Souza, D.N., Waninger, A., Tran, P., Iyengar, S., et al. (2006). A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology, 67, 1411-1420.
47. Woolf, C.J. (2004). Pain: Moving from symptom control toward mechanism-specific pharmacologic management. Annals of Internal Medicine, 140, 441-451.